#Jerome Berko
Explore tagged Tumblr posts
larryland · 6 years ago
Text
Shakespeare & Company Announces 2018 Season Gala
Shakespeare & Company Announces 2018 Season Gala
(Lenox, MA) – Shakespeare & Company celebrates its 41st Season, Saturday, June 30th with its annual Gala. This year’s event will honor Trustee Michael A. Miller for his twenty-five years of dedication to the Company. The very special evening will feature a one-night-only performance blending music and theatre from Silkroad Ensemble and Shakespeare & Company’s venerated performers.
Co-chaired by…
View On WordPress
0 notes
larryland · 6 years ago
Text
(Lenox, MA) –  Shakespeare & Company announces the addition of three new Board members to the Company’s Board of Trustees. The new members joining the Board are Nancy Edman Feldman, Erick Lucera, and Andrew D. Rothstein.
“I’m thrilled with the steady increase in Board membership over the last few years, and the diverse group of talented people we’ve added this year,” said Board Chair Kenneth Werner. “Their prior experience on other non-profit Boards and variety of work experiences should add a lot to our Board of Trustees.”
Tumblr media
Andrew D. Rothstein
Tumblr media
Erick Lucera
Tumblr media
Nancy Edman Feldman
The 2018 Shakespeare & Company Board of Trustees includes: Kenneth E. Werner (Chair), Jeffrey B. Konowitch (Vice Chair), Barry R. Shapiro (Vice Chair), Michael Helfer (Treasurer), Michael A. Miller (Clerk), Jerome Berko, Sandra Bourgeois, George Camarda, Kevin G. Coleman, Gerald Friedman, M.D., Ph.D., Michael Fuchs, Phoebe L. Giddon, Dr. Beverly Hyman, Jennie M. Jadow, Dennis Krausnick, Barri Marks, Maureen O’Hanlon, Helga S. Orthofer, Tina Packer, Claudia Perles, Scott Rubinow, William M. Ryan, David A. Smith, Robert B. Strassler, John Douglas Thompson, and Suzanne Werner.
“Each of these fine people bring a unique expertise to our Board,” said Artistic Director Allyn Burrows. “We are fortunate to have them take a keen interest in what we put forward with our work. It’s a pleasure to welcome them.”
The newly appointed trustees each began their term as board member of Shakespeare & Company this August. More information on each new trustee below.
About the Trustees Nancy Edman Feldman (Owner, Nancy Edman Interiors; ASID, IFDA) has interior design expertise in developing new environments customized for her clients, focusing on their personal lifestyle requirements, while creating beautifully high-styled surroundings; introducing as many sustainable and energy-saving products as possible. She has over 50+ years of membership in ASID, the American Society of Interior Designers as well as membership in IFDA, the International Furnishings and Design Association. Also, Nancy Edman Interiors –  New York and  Boston. She graduated from Brandeis University ’60 (Bachelor’s Degree, Theatre/Theater & Fine Arts) and from the Parsons School of Design (Field of Study, Interior Design). Affiliations include Ruth L. Strauss, Inc.; HCG Associates, Inc.; Nancy Edman Interiors, NYC; University of Massachusetts Medical School Foundation Board, Past Member; Boston Center for Adult Education, Past Board Member; New Center for Arts and Culture, Past Board Member; Berkshire Museum, Current Board Member; Terezin Music Foundation, Board Member. Current Board Member; University Of Massachusetts Medical School Foundation (UMMS), she chaired the Campaign for Research At UMMS in 1999 to 2001 to build the flagship research building at the medical school, raising more  than $50,000,000, for theThe Aaron Lazare Research Building.
Erick Lucera joined Valeritas as Chief Financial Officer in August 2016. Prior to joining Valeritas, Mr. Lucera served as Chief Financial Officer, Treasurer and Secretary of Viventia Bio. From 2012 to 2015, he was Vice President, Corporate Development at Aratana Therapeutics, a veterinary biopharmaceutical company. While at Aratana, he helped grow the company’s product pipeline through a series of acquisitions and in licensing transactions financed through 5 public and private offerings of nearly $250 million. In 2012, he served as Vice President, Corporate Development at Sunshine Heart, a medical device manufacturer. Before his career as a healthcare company executive, Mr. Lucera spent over 15 years in investment management as a healthcare analyst at Eaton Vance, the portfolio manager of the Triathlon Life Sciences Fund at Intrepid Capital and as head of the healthcare research team at Independence Investments. He holds a CPH from Harvard University, and MS in quantitative finance from Boston College, an MBA from Indiana University Bloomington, and a BS in accounting from the University of Delaware. Mr. Lucera has obtained CFA, CMA, and CPA designations.
Andy Rothstein is a trusts and estates lawyer at Goulston & Storrs PC in Boston, Massachusetts.  Andy’s practice focuses on tax-efficient wealth transfer planning.  In his work, Andy provides clients with a full understanding of legal and tax rules associated with accumulating, managing, and transferring wealth, helping them to develop legal structures and tax strategies to transfer and preserve wealth.  He also serves as a trustee for charitable and non-charitable trusts, owning marketable and non-marketable assets.  In addition, Andy counsels trustees about their duties, helping them to comply with legal and tax requirements related to the administration of trusts, and has particular experience with trusts holding direct and indirect interests in real estate.  Andy is a co-chair of Goulston & Storrs’s Private Client & Trust Group.
About Shakespeare & Company Located in the Berkshires of Western Massachusetts, Shakespeare & Company is one of the largest Shakespeare Festivals in the country. Founded in 1978, the organization attracts over 40,000 patrons annually. The Company is also home to Shakespeare & Company’s internationally renowned Center for Actor Training and nationally renowned and award-winning Education Program. More information is available at www.shakespeare.org.
Shakespeare & Company Announces New Board Members (Lenox, MA) –  Shakespeare & Company announces the addition of three new Board members to the Company's Board of Trustees.
0 notes